Seek truth from facts, competitive symbiosis
07
2026-07
In July 2026, at the Zhengqing Group’s second-quarter Amoeba Promotion Conference, outstanding teams and individuals recognized for their innovative breakthroughs and managerial excellence were honored. Huang Xuemei, Deputy Manager of the Property Management Office under the Administrative Center, was awarded the title of “Amoeba Individual Benchmark” in recognition of her exceptional performance in her logistics role.
07
2026-07
On July 16, 2026, the unveiling and signing ceremony for the demonstration site of the “Rheumatism and Pain Triple Sequential Therapy—Thousand Counties, Ten Thousand Towns Initiative” was solemnly held at the Shimen County Traditional Chinese Medicine Hospital. Attending the event were more than one hundred guests, including Deputy County Mayor Tian Yan of the Shimen County People’s Government, Director Deng Dewen of the Shimen County Health Commission, and other relevant leaders; Yi Xianfeng, Party Secretary of the Shimen County Traditional Chinese Medicine Hospital, along with members of the hospital’s leadership team and key personnel from relevant departments; as well as Li Yanping, Deputy Director of Academician Liu Liang’s Expert Workstation, and the project team.
07
2026-07
On July 22, the on-site exchange meeting for the “Rheumatism and Pain Triple Sequential Therapy—Thousand Counties, Ten Thousand Towns Initiative” was successfully held at the Guanyang County Traditional Chinese Medicine Hospital in Guangxi. Attending the event were Tang Peiyou, Secretary of the Party Committee of the Guanyang County Health Commission; Tang Jun, President and Party Secretary of the Guanyang County TCM Hospital; Vice Presidents Xu Siyin, Liu Zunwei, and Jiang Xiaolan; Li Yanping, Deputy Director of Academician Liu Liang’s Expert Workstation; He Zhiguo, National Project Director of the Thousand Counties, Ten Thousand Towns Initiative; staff members of the Academician Workstation; as well as leaders and key physicians from medical institutions within the Guanyang County Medical Consortium—totaling more than 100 participants.
07
2026-07
From July 17 to 20, the 13th Annual Academic Conference of the TCM Immunology Professional Committee of the World Federation of Chinese Medicine Societies and the 2026 Expanded Meeting of the TCM Immunology Branch of the Chinese Society of Immunology were held at the Liyuan International Hotel in Nanning, Guangxi. The event brought together more than 300 experts and scholars in immunology and rheumatology from mainland China, Hong Kong, Macao, and Taiwan, focusing on cutting-edge developments in basic research and clinical translation in TCM immunology. As a vice-presidential unit of the societies, Zhengqing Group was invited to attend. Liu Liang, the group’s chief scientist and an academician of the Chinese Academy of Engineering, delivered a keynote address, offering an in-depth analysis of the core research findings behind Zhengqing Fengtongning’s innovative formulation, which drew widespread attention from the audience.
07
2026-07
On the morning of July 17, the Zhengqing Group’s second-quarter Amoeba Management Promotion Conference was held in the fifth-floor conference room at the Group’s headquarters in Huaihua. The meeting conducted a comprehensive review of the progress and results achieved in implementing the Amoeba Management model during the second quarter, outlined plans for enhancing management practices and ensuring the effective rollout of the oversight system, recognized exemplary individuals and teams, and further aligned the entire workforce around a shared vision and consensus on business operations, thereby driving the Amoeba Management approach to greater depth and practical implementation. Wu Feichi, Chairman and President of the Group, along with members of the Group’s executive team, attended the meeting. Corporate consultant Xiao Liang was invited to participate, and rotating President Long Xianjun presided over the proceedings.
07
2026-07
Recently, the National Health Commission officially issued the “National Essential Medicines List (2026 Edition)” (Guo Wei Yao Zheng Fa [2026] No. 17). The new edition will be fully implemented starting September 1, 2026. The total number of items on the list has been expanded from 685 to 794, including 476 Western medicines and 318 traditional Chinese medicines, with a stronger focus on clinically essential drugs and medications for common and chronic conditions at the primary care level, thereby comprehensively improving public access to basic medicines. Hunan Zhengqing Pharmaceutical Group Co., Ltd. has had a total of 24 products across 38 specifications successfully included in the new National Essential Medicines List, comprising 3 traditional Chinese medicines and 21 chemical drugs. Its flagship product, Zhengqing Fengtongning Sustained-Release Tablets and Tablets, remains on the list, while two additional commonly used dosage forms—Acetaminophen Tablets and Acyclovir Tablets—have been added, further bolstering the company’s position in the primary‑care drug market under favorable policy support.
07
2026-07
From July 12 to 15, 2026, the Zhengqing Group’s 2026 Mid-Year Marketing Conference, themed “Forging Swords on Wugong Mountain—Six Veins Usher in a New Era,” was successfully held at the Junlan Hot Spring Hotel on Wugong Mountain in Jiangxi Province. More than 300 frontline marketing professionals and representatives from functional departments gathered on Wugong Mountain for four days of comprehensive sessions to review first-half performance, analyze emerging industry trends, and unveil the full “Six Veins Divine Sword” operational framework for the second half of the year, aligning thinking and setting clear direction for the market‑driving phase ahead.
07
2026-07
On July 7, the on-site exchange meeting for the “Rheumatism and Pain Triple Sequential Therapy—Thousand Counties, Ten Thousand Towns Initiative” was held in the fourth-floor conference room of the Administrative Building at Xia County People’s Hospital. This marked the official establishment of the initiative’s demonstration site at Xia County People’s Hospital, representing a solid step forward in enhancing primary healthcare service capacity in Xia County.
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地